Evidence-based guides on GLP-1 medications — what to expect, how they work, and how to get the most from your treatment.
Wondering what Ozempic results actually look like week by week? This guide breaks down the full timeline — from your first 0.25 mg dose through month six — using real clinical trial data.
Zepbound and Mounjaro are the same drug — tirzepatide — just approved for different conditions. Here's what that means for your coverage, dosing, and weight loss expectations.
Ozempic plateaus are frustrating but common — and usually fixable. Learn why semaglutide stops working and the evidence-backed steps to get your weight loss moving again.
Mounjaro (tirzepatide) produces an average of 20.2% body weight loss in clinical trials — far outpacing older medications. Here's what the data really means for your results.
The Wegovy dosing schedule spans 16+ weeks across five dose levels, from 0.25 mg to 2.4 mg. This guide explains what happens at each step and how to navigate side effects without giving up.
Starting Ozempic and wondering if what you're feeling is normal? This guide covers the most common first-week side effects — nausea, fatigue, GI changes — and exactly how to manage them.
Wondering when Mounjaro starts working? This week-by-week breakdown shows what to expect from week 1 through week 72, backed by SURMOUNT trial data. Understand the timeline so you can stay the course.
Ozempic and Wegovy are both semaglutide — so which one is actually better for weight loss? We break down the doses, trial data, costs, and how they compare to newer options like tirzepatide.
Ozempic starts affecting appetite within weeks, but peak weight loss builds over 12–18 months. Here's exactly what to expect at each stage of your journey.
Most people on Ozempic hit a plateau between months 4 and 8. Here's the science behind why progress stalls — and evidence-based strategies to break through.
Use our free calculator to see projected weight loss based on real clinical trial data.
Try the calculator →